The New York Times' Andrew Pollack just published an interesting article on J. Craig Venter, the scientists and businessman who became a household name (at least around geneticists' dinner tables) by competing with Francis Collin's federally funded team to complete the Human Genome Project.
Venter's company Synthetic Genomics created a sensation in May when they announced the creation of the first synthetic organism. I covered the finding for BioTechniques: Venter Creates First Synthetic Life. Recently Venter has focused on his efforts to use algae as a biofuel. Despite receiving funding from companies like Exxon Mobil and BP, Venter's algae efforts have generated far less of a media frenzy.
The article takes a look at why Venter's more industrial aims haven't generated the kind of success that his research and science based work has. It also gives some interesting insight into Venter himself.
No comments:
Post a Comment